Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Julie Gralow
Person

Julie Gralow

Tracked across 2 events · 80 articles · First seen May 29, 2026 · Last active Jun 09, 2026

Sentiment
60
Attention
7
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
6 50
Tech
Targeted Cancer Drugs Boost Survival
A growing number of Americans are living longer with cancer due to significant advancements in targeted drugs and a deeper understanding of cancer biology. The American Cancer Society>>> reports that 7 out of 10 cancer…
Impact: Julie Gralow>>>, chief medical officer of American Society of Clinical Oncology>>>, highlights the future need for full genomic profiling of every cancer.
Jun 03, 2026 · 6 articles
7 70
Tech
Revolution_Medicines' daraxonrasib extends pancreatic cancer survival
Researchers have reported a significant breakthrough in treating advanced pancreatic cancer with an experimental pill called daraxonrasib, developed by Revolution Medicines. The daily pill nearly doubled the median survival time for patients whose metastatic cancer…
Impact: Julie Gralow, chief medical officer at American Society of Clinical Oncology, called the Daraxonrasib findings a 'grand slam' due to the drug's ability to target the KRAS mutation in Pancreatic cancer.
May 29, 2026 · 74 articles
NEWSDESK
Track Julie Gralow live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.